Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues

Tiziana Parisi1, Tina L Yuan, Ann Marie Faust

  • 1Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Insights

The retinoblastoma protein (pRB) and E2F3

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • The tumor suppressor retinoblastoma protein (pRB) inhibits cell proliferation by binding to E2F transcription factors.
  • Studying pRB and E2F interactions is challenging due to the embryonic lethality of mice lacking both Rb and E2f genes.

Purpose of the Study:

  • To investigate the role of E2F3 in developmental defects and tumor formation in pRB-deficient mice.
  • To establish a viable mouse model for studying Rb and E2f3 interactions.

Main Methods:

  • Generated embryonic stem cells and chimeric mice lacking both Rb and E2f3.
  • Analyzed developmental defects (cataracts, retinal dysplasia) and tumor development in Rb(-/-); E2f3(-/-) chimeric mice.

Main Results:

  • Loss of E2F3 suppressed cataracts but worsened retinal dysplasia in Rb(-/-) chimeras.
  • E2F3 was dispensable for pituitary and thyroid tumor development in pRB-deficient mice.
  • E2F3 inactivation prevented pulmonary neuroendocrine hyperplasia, a precursor to small-cell lung carcinoma.

Conclusions:

  • E2F3 plays opposing roles in different developmental defects associated with pRB loss.
  • E2F3 is not essential for pituitary and thyroid tumor formation in Rb(-/-) mice.
  • E2F3 inactivation suppresses a key preneoplastic lesion in small-cell lung carcinoma, suggesting a potential therapeutic target.